De Novo Mutations in Moderate or Severe Intellectual Disability

  title={De Novo Mutations in Moderate or Severe Intellectual Disability},
  author={Fadi F. Hamdan and Myriam Srour and Jose-Mario Capo-Chichi and Hussein Daoud and Christina Nassif and Lysanne Patry and Christine Massicotte and Amirthagowri Ambalavanan and Dan Spiegelman and Ousmane Diallo and {\'E}douard Henrion and Alexandre Dionne‐Laporte and Anne Fougerat and Alexey V. Pshezhetsky and Sunita Venkateswaran and Guy A. Rouleau and Jacques L. Michaud},
  journal={PLoS Genetics},
Genetics is believed to have an important role in intellectual disability (ID). Recent studies have emphasized the involvement of de novo mutations (DNMs) in ID but the extent to which they contribute to its pathogenesis and the identity of the corresponding genes remain largely unknown. Here, we report a screen for DNMs in subjects with moderate or severe ID. We sequenced the exomes of 41 probands and their parents, and confirmed 81 DNMs affecting the coding sequence or consensus splice sites… 

Figures and Tables from this paper

De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies
Intellectual disability (ID) has an estimated prevalence of 1.5–2%. In most affected individuals, its genetic basis remains unclear. Whole exome sequencing (WES) studies have identified a multitude
De novo loss-of-function mutations in WAC cause a recognizable intellectual disability syndrome and learning deficits in Drosophila
A clinically recognizable ID syndrome, caused by de novo loss-of-function mutations in WAC is defined, and WAC can be added to the list of ID genes with a role in transcription regulation through histone modification.
De novo mutations in HNRNPU result in a neurodevelopmental syndrome
A novel neurodevelopmental syndrome is defined, with a likely mechanism of haploinsufficiency, associated with heterozygous de novo mutations in HNRNPU, found via trio‐based exome sequencing.
Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis
TCF4 is highlighted as a frequent cause of moderate to profound ID and the clinical spectrum associated to TCF4 mutations to nonspecific ID is broadened to include all known disease-causing genes.
De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies.
Mutations in TBR1 gene leads to cortical malformations and intellectual disability.
Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families
The high yield of AR mutations for ID indicated that this approach has excellent clinical potential and should inform clinical diagnostics, including clinical whole exome and genome sequencing, for populations in which consanguinity is common.


Genome sequencing identifies major causes of severe intellectual disability
Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.
Extended spectrum of MBD5 mutations in neurodevelopmental disorders
The mutation spectrum in MBD5 gene is extended and a de novo nonsense mutation associated with a much more damaging phenotype is identified for the first time, contributing to refine the associated phenotype of neurodevelopmental disorder.
Diagnostic exome sequencing in persons with severe intellectual disability.
De novo mutations represent an important cause of intellectual disability; exome sequencing was used as an effective diagnostic strategy for their detection.
TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion
A 12‐year‐old male patient diagnosed with growth retardation and ID is described, which is the first case of a deletion at 2q24.2 involving only TBR1, which strengthens the previously suggested hypothesis that this gene is a strong candidate for the ID phenotype.
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
It is shown, using whole-exome sequencing of 928 individuals, including 200 phenotypically discordant sibling pairs, that highly disruptive (nonsense and splice-site) de novo mutations in brain-expressed genes are associated with autism spectrum disorders and carry large effects.
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors and support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold.